Literature DB >> 33922488

Fucoidan from Laminaria japonica Inhibits Expression of GLUT9 and URAT1 via PI3K/Akt, JNK and NF-κB Pathways in Uric Acid-Exposed HK-2 Cells.

Yu Zhang1,2, Xiaohui Tan1,2, Zhen Lin1, Fangping Li1, Chunyan Yang2, Haiying Zheng2, Lingyu Li2, Huazhong Liu1, Jianghua Shang2.   

Abstract

This work aimed to investigate the effect of fucoidan (FPS) on urate transporters induced by uric acid (UA). The results showed that UA stimulated the expression of glucose transporter 9 (GLUT9) and urate transporter 1 (URAT1) in HK-2 cells, and FPS could reverse the effect. Moreover, UA could activate NF-κB, JNK and PI3K/Akt pathways, but both pathway inhibitors and FPS inhibited the UA-induced activation of these three pathways. These data suggested that FPS effectively inhibited the expression induction of reabsorption transporters URAT1 and GLUT9 by UA, through repressing the activation of NF-κB, JNK and PI3K/Akt signal pathways in HK-2 cells. The in vitro research findings support the in vivo results that FPS reduces serum uric acid content in hyperuricemia mice and rats through inhibiting the expression of URAT1 and GLUT9 in renal tubular epithelial cells. This study provides a theoretical basis for the application of FPS in the treatment of hyperuricemia.

Entities:  

Keywords:  fucoidan; glucose transporter 9; urate transporter 1; uric acid

Year:  2021        PMID: 33922488     DOI: 10.3390/md19050238

Source DB:  PubMed          Journal:  Mar Drugs        ISSN: 1660-3397            Impact factor:   5.118


  25 in total

Review 1.  Pathogenesis of gout.

Authors:  Hyon K Choi; David B Mount; Anthony M Reginato
Journal:  Ann Intern Med       Date:  2005-10-04       Impact factor: 25.391

Review 2.  Use of fucoidan to treat renal diseases: A review of 15 years of clinic studies.

Authors:  Jing Wang; Lihua Geng; Yang Yue; Quanbin Zhang
Journal:  Prog Mol Biol Transl Sci       Date:  2019-04-10       Impact factor: 3.622

3.  Fucoidan from Undaria pinnatifida induces apoptosis in A549 human lung carcinoma cells.

Authors:  Hye-Jin Boo; Jae-Hee Hyun; Sang-Cheol Kim; Jung-Il Kang; Min-Kyoung Kim; Sun-Yeou Kim; Heeyeong Cho; Eun-Sook Yoo; Hee-Kyoung Kang
Journal:  Phytother Res       Date:  2011-07       Impact factor: 5.878

Review 4.  Regulation of uric acid excretion by the kidney.

Authors:  Michael S Lipkowitz
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

5.  Low molecular weight fucoidan ameliorates diabetic nephropathy via inhibiting epithelial-mesenchymal transition and fibrotic processes.

Authors:  Jihui Chen; Wentong Cui; Quanbin Zhang; Yingli Jia; Yi Sun; Lin Weng; Dali Luo; Hong Zhou; Baoxue Yang
Journal:  Am J Transl Res       Date:  2015-09-15       Impact factor: 4.060

6.  Uric acid induces renal inflammation via activating tubular NF-κB signaling pathway.

Authors:  Yang Zhou; Li Fang; Lei Jiang; Ping Wen; Hongdi Cao; Weichun He; Chunsun Dai; Junwei Yang
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

Review 7.  Efficacy and Safety of Chinese Medicinal Herbs for the Treatment of Hyperuricemia: A Systematic Review and Meta-Analysis.

Authors:  Jianping Lin; Shaoqing Chen; Shuzhen Li; Meili Lu; Yanan Li; Youxin Su
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-13       Impact factor: 2.629

8.  Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats.

Authors:  Olga N Pozharitskaya; Alexander N Shikov; Natalya M Faustova; Ekaterina D Obluchinskaya; Vera M Kosman; Heikki Vuorela; Valery G Makarov
Journal:  Mar Drugs       Date:  2018-04-18       Impact factor: 5.118

9.  Production Inhibition and Excretion Promotion of Urate by Fucoidan from Laminaria japonica in Adenine-Induced Hyperuricemic Mice.

Authors:  Dayan Zhang; Huazhong Liu; Ping Luo; Yanqun Li
Journal:  Mar Drugs       Date:  2018-11-27       Impact factor: 5.118

10.  Fucoidan Induces Apoptosis and Inhibits Proliferation of Hepatocellular Carcinoma via the p38 MAPK/ERK and PI3K/Akt Signal Pathways.

Authors:  Yifei Duan; Jingjing Li; Xue Jing; Xueli Ding; Yanan Yu; Qingxi Zhao
Journal:  Cancer Manag Res       Date:  2020-03-09       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.